Loco-regional failures in head and neck cancer: Can they be effectively salvaged by nonsurgical therapeutic modalities?

International Journal of Clinical Oncology

Volumn 8, Issue 1, 2003, Pages 31-39

  Datta, Niloy Ranjan ^a   Nagar, Yoodhvir Singh ^a   Singh, Shalini ^a   Naryan, Laxmi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chemoradiation; Head and neck cancer; Re irradiation; Salvage therapy

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DRUG RESPONSE; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MORBIDITY; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT CANCER; SALVAGE THERAPY; TREATMENT FAILURE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; RADIATION DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037295412     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101470300004     Document Type: Article

References (38)

1. Vokes EE, Weichselbaun RR, Lippman SM, et al. (1993) Head and neck cancer. N Engl J Med 328:184-194
2. Kotwall C, Sako K, Razack MS, et al. (1987) Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 154:439-442
3. Nishijima W, Takooda S, Tokita N, et al. (1993) Analysis of distant metastases in squamous cell carcinoma of the head and neck and lesions above clavicle at autopsy. Arch Otolaryngol 119:65-68
4. Haraf DJ, Wiechselbaum RR, Vokes EE (1996) Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol 7:913-918
5. Ganly I, Kaye SB (2000) Recurrent squamous-cell carcinoma of the head and neck: overview of current therapy and future prospects. Ann Oncol 11:11-16
6. Stell PM (1989) Survival times in end-stage head and neck cancer. Eur J Surg Oncol 15:407-410
7. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346
8. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
9. Cox DR (1972) Regression models and life tables. J R Stat Soc B 34:187-220
10. Khuri FR, Shin DM, Glisson BS, et al. (2000) Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Semin Oncol 27(Suppl 8):25-33
11. Eisbruch A, Dawson L (1999) Re-irradiation of head and neck tumors: benefits and toxicities. Haemat Oncol Clin N Am 13:825-836
12. Haraf DJ, Wiechselbaum RR (1988) Treatment selection in T1 and T2 vocal cord carcinoma. Oncology 2:41-47
13. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690
14. Schaefer U, Micke O, Schueller P, et al. (2000) Recurrent head and neck cancer: re-treatment of previously irradiated areas with combined chemotherapy and radiation therapy - results of a prospective study. Radiology 216:371-376
15. Crevoisier RD, Bourhis J, Domenge C, et al. (1998) Full dose re-irradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16:3556-3562
16. Stevens KR Jr, Britsch A, Moss WT (1994) High-dose re-irradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 29:687-698
17. Pryzant RM, Wendt CD, Delclos L, et al. (1992) Re-treatment of nasopharyngeal carcinoma in 53 patients. Int J Radiat Oncol Biol Phys 22:941-947
18. Wang CC (1987) Re-irradiation of recurrent nasopharyngeal carcinoma - treatment techniques and results. Int J Radiat Oncol Biol Phys 13:953-956
19. Langlois D, Hoffstetter S, Malissard L, et al. (1988) Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in Center Alexis Vautrin. Int J Radiat Oncol Biol Phys 14:849-853
20. Mazeron JJ, Langlois D, Glaubiger D, et al. (1987) Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5 year results of 70 cases. Int J Radiat Oncol Biol Phys 13:957-962
21. Puthawala AA, Syed AM, Gates TC (1985) Iridium-192 implants in the treatment of tonsillar region malignancies. Arch Otolaryngol 111:812-815
22. Levendag PC, Meeuwis CA, Visser AG (1992) Re-irradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy. Radiother Oncol 23:6-15
23. Fontanesi J, Hetzler D, Ross J (1989) Effect of dose rate on local control and complications in the re-irradiation of head and neck tumors with interstitial iridium-192. Int J Radiat Oncol Biol Phys 17:365-369
24. Pomp J, Levendag P, van Putten W (1988) Re-irradiation of recurrent tumour in the head and neck. Am J Clin Oncol 11:543-549
25. Haraf DJ, Vokes EE, Panje W, et al. (1991) Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol 14:419-426
26. Haraf DJ, Vokes EE, Wiechselbaum RR, et al. (1992) Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor prognostic head and neck cancer. Laryngoscope 102:630-636
27. Gandia D, Wibault P, Guillot T, et al. (1993) Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer. Head Neck 15:8-15
28. Weppelmann B, Wheeler RH, Peters GE, et al. (1992) Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and re-irradiation. Int J Radiat Oncol Biol Phys 22:1051-1056
29. Emami B, Bignardi M, Spector GJ, et al. (1987) Re-irradiation of recurrent head and neck cancers. Laryngoscope 97:85-88
30. Spencer SA, Harris J, Wheeler RH, et al. (2001) RTOG 96-10: Re-irradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 51:1299-1304
31. Skolyzewski J, Korzeniowski S, Reinfuss M (1980) The re-irradiation of recurrences of head and neck cancer. Br J Radiol 53:462-465
32. Eisbruch A, Shewach D, Bradford C, et al. (2001) Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. J Clin Oncol 19:792-799
33. Degradin M, Oliveira, Geoffrois L, et al. (1998) An EORTC-ESCG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Ann Oncol 9:1103-1107
34. Smith R, Lew D, Rodriguez G, et al. (1996) Evaluation of topotecan in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. A phase II Southwest Oncology Group study. Invest New Drugs 14:403-407
35. Robert F, Soong SJ, Wheeler RH (1997) A phase II study of topotecan in patients with recurrent head and neck cancer: identification of an active agent. Am J Clin Oncol 20:298-302
36. Wang CC (1994) To re-irradiate or not to re-irradiate? Int J Radiat Oncol Biol Phys 29:913
37. Emami B, Lyman J, Brown A, et al. (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109-122
38. Jung H, Beck-Bornholdt H, Svoboda V, et al. (2001) Quantification of late complications after radiotherapy. Radiother Oncol 61:233-246